Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Under7 Co. Ltd. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is concentrated under 1 distinct examiner, WALTER E WEBB, who is also the busiest examiner for the portfolio. The work is situated within a distinct art unit, indicating a highly focused technical review process for the company's current patent applications.
With the pending office action assigned to WALTER E WEBB, the administrative complexity for the portfolio is minimal. This interaction allows practitioners to focus their efforts on the specific preferences and historical tendencies of the individual examiner. The fact that the busiest examiner has a pending action reflects the small scale of the active docket. This concentration in the art unit ensures that the legal strategy does not need to account for varying procedural standards across different departments.
The alignment of the examiner and the art unit for the pending office action provides a straightforward path for prosecution. There are no competing priorities or conflicting examiner styles to navigate within the Under7 Co. Ltd. portfolio at this time. This environment offers a clear opportunity to resolve the matter with a focused approach to the specific requirements of the Biotechnology & Pharmaceuticals sector as interpreted by WALTER E WEBB.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WEBB, WALTER E | 1 | 46.3% | +18.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18786850 | COSMETIC COMPOSITION, COSMETIC, METHOD FOR APPLYING COSMETIC COMPOSITION, AND METHOD FOR APPLYING COSMETIC | WEBB, WALTER E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18786850 | COSMETIC COMPOSITION, COSMETIC, METHOD FOR APPLYING COSMETIC COMPOSITION, AND METHOD FOR APPLYING COSMETIC | WEBB, WALTER E | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18786850 | COSMETIC COMPOSITION, COSMETIC, METHOD FOR APPLYING COSMETIC COMPOSITION, AND METHOD FOR APPLYING COSMETIC | WEBB, WALTER E | 1612 | §103§112 | Non-Final OA | — | Pending | Jul 29, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUnder7 Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Walter E Webb has the most, with 1 of Under7 Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.